Firms
Theme

SATL

Satellogic Inc. Class A · NASDAQ

News

6 latest

No direct coverage yet · Showing articles that mention SATL

Zacks Investment Research

Planet Labs Drops 25.8% in a Month as Investors Weigh Execution Risk

Planet Labs (PL) shares declined 25.8% over the past month despite strong defense and intelligence revenues (up 93.3% YoY) and a substantial $815 million backlog. The company expects Q3 revenues of $101-$105 million, representing a sequential decline due to satellite delivery timing shifts. With planned annual capital spending of $100-$115 million and a premium valuation of 8.8X forward sales, PL faces execution risks, though long-term defense demand remains supportive.

Zacks Investment Research

Planet Labs' Berlin Expansion Could Reshape Its European Growth Path

Planet Labs opened a new 5,700-square-meter Berlin satellite manufacturing facility capable of producing up to 60 satellites annually to serve growing European sovereign demand. The company's Defense and Intelligence revenues surged 93.3% year-over-year, with EMEA revenues jumping over 130% in Q2. However, the expansion comes with increased capital spending ($100-$115M expected for fiscal 2027) and weakening free cash flow, raising concerns about returns on the new capacity.

Zacks Investment Research

Should Investors Buy Planet Labs as Growth Meets Premium Valuation?

Planet Labs (PL) reported Q2 revenues surging 58.1% to $116.1M with Defense and Intelligence growing 93.3%, backed by an $815M backlog supporting 40-43% fiscal 2027 growth projections. However, the company trades at a premium 8.8X forward sales multiple with negative operating results and heavy reinvestment needs, prompting analysts to recommend a measured approach despite strong growth momentum.

Zacks Investment Research

PL Wins ESA Deal: Can Space-Based Disaster Monitoring Drive Growth?

Planet Labs' subsidiary Sinergise Solutions was selected by the European Space Agency to develop Slovenia's Space Resilience Node, a 12-month pilot project combining Copernicus data and PlanetScope imagery for automated disaster detection and response. The company continues expanding its government and defense market presence following recent wins including an $8M NGA award, a German government contract worth up to €25M, and a European defense contract.

Zacks Investment Research

Planet Labs Down 51% in 6 Months: Is This a Buying Opportunity?

Planet Labs' stock has fallen 50.6% over six months despite 58% revenue growth and strong defense demand. The company reported $116M in Q2 revenues with defense revenues surging 90% YoY, backed by an $815M backlog and $865M in liquidity. While the sharp decline presents a potential buying opportunity given strong fundamentals, elevated valuation (11.89X forward P/S) and execution risks remain concerns.

Zacks Investment Research

Can Planet Labs' 20-Satellite Launch Strengthen Its Global Coverage?

Planet Labs launched 20 satellites via SpaceX's Transporter-18 mission, including its second Tanager satellite with hyperspectral imaging for methane detection, 18 SuperDoves for enhanced global monitoring, and a Google Suncatcher prototype. The launch marks PL's 40th successful mission and brings its total deployed satellites to 718. However, PL's stock has underperformed significantly, down 50.6% over six months and trading at a premium valuation of 11.89X forward price-to-sales compared to the industry average of 2.93X.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SATL · 0 threads

Sign in to post on $SATL

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev